CLBSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (15 9月 2022 @ 13:00):

Stats
本日の出来高	26.95M
平均出来高	0
時価総額	3.35M
EPS	$-0.110 ( Q2 \| 2022-08-04 )
Last Dividend	$0.310 ( 2013-10-28 )
Next Dividend	$0 ( N/A )
P/E	-1.082 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0290 (6.80%)

AADI -1.18%

ABCL 2.01%

ABCM 0.04%

ABEO -3.54%

ABIO -0.28%

ABOS -2.10%

ABSI 0.17%

ABUS -2.96%

ABVX -2.56%

ACAD -1.67%

ACER -17.95%

ACET -3.74%

ACGN 1.29%

ACHL -4.15%

ACHV -0.43%

ACIU -0.87%

ACLX -0.70%

ACRV -2.64%

ACST -1.30%

ACXP 0.36%

ADAG 1.80%

ADAP -2.10%

ADGI 0.87%

ADIL 0.88%

ADMA -2.72%

ADPT 0.44%

ADTX -4.86%

ADVM -2.45%

ADXN -1.60%

AEON -1.10%

AEZS -3.51%

AFMD -2.47%

AGEN -0.54%

AGIO -1.30%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -5.42%

AKRO -3.23%

AKTX 3.23%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -3.67%

ALGS -3.70%

ALKS -0.29%

ALLK -8.55%

ALLO -6.65%

ALLR -2.16%

ALNA 3.16%

ALNY 0.08%

ALPN 0.02%

ALPX 0.00%

ALRN -1.68%

ALT -9.78%

ALVR -2.58%

ALXN 0.00%

ALXO -10.81%

ALZN -2.05%

AMRN 1.88%

AMTI -3.13%

ANAB -0.04%

ANEB -4.55%

ANGN 0.00%

ANIX -1.40%

ANL -3.22%

ANNX -1.53%

ANPC -3.15%

APGE -1.09%

APGN 8.48%

APGNW 30.65%

APLM 0.61%

APLS -0.66%

APLT -4.17%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 3.38%

APTX 3.17%

APVO 0.95%

ARAV -13.39%

ARCT -4.38%

ARDS -14.23%

ARDX -1.41%

ARGX -1.16%

ARNA 0.00%

ARPO -0.90%

ARQT -1.46%

ARTL -3.62%

ARTLW 0.00%

ARVN 3.25%

ARWR -3.05%

ASLN -1.83%

ASMB -0.65%

ASND -2.61%

ATAI -0.89%

ATHA 5.71%

ATHE 1.12%

ATHX -33.50%

ATNF -0.98%

ATOS 4.85%

ATRA -0.12%

ATXI 0.00%

ATXS -0.72%

AUPH -1.34%

AURA 0.37%

AUTL -1.30%

AVBP -7.11%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -4.82%

AVTX -1.25%

AVXL -2.72%

AXLA 0.00%

AXSM -2.25%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.07%

BCAB 3.61%

BCDA -1.55%

BCDAW -41.77%

BCEL 0.00%

BCLI 7.23%

BCRX -1.13%

BCTX 4.03%

BCTXW -16.28%

BCYC 0.60%

BDRX -2.33%

BDTX -1.06%

BEAM -0.87%

BFRA -2.91%

BGNE -3.04%

BIOR -3.79%

BIVI -0.96%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.02%

BLTE -0.62%

BLU 0.03%

BLUE -0.83%

BMEA -7.12%

BMRN -0.59%

BNOX -2.51%

BNTC -2.11%

BNTX -1.25%

BOLD -8.58%

BOLT -0.05%

BPMC -0.93%

BPTH 0.48%

BPTS -13.47%

BRNS 0.00%

BRTX -0.47%

BTAI 9.48%

BTTX 1.35%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 5.08%

CABA -0.90%

CADL -0.35%

CALA 0.00%

CALC -1.57%

CALT -0.67%

CAPR -3.02%

CARA 9.39%

CARM 2.61%

CASI -3.72%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.34%

CCCC -2.76%

CCXI 0.00%

CDAK 0.00%

CDIO -5.63%

CDIOW 24.00%

CDMO -1.41%

CDMOP 0.04%

CDT 1.63%

CDTTW -39.60%

CDTX -1.05%

CDXC -1.02%

CDXS 4.66%

CELC -3.24%

CELU -3.33%

CELUW 11.80%

CERC -1.68%

CERE -0.46%

CERO -5.39%

CEROW 0.60%

CFRX -27.95%

CGEM -3.96%

CGEN -3.31%

CGON -0.89%

CGTX -1.14%

CHMA -6.00%

CHRS -0.63%

CINC 0.00%

CING 2.39%

CINGW 34.95%

CKPT -2.63%

CLBS -16.75%

CLDX -3.38%

CLGN 0.60%

CLLS -4.04%

CLNN 2.42%

CLNNW 0.00%

CLRB 5.56%

CLSD -2.00%

CLSN -0.68%

CLVS 0.00%

CMMB 0.97%

CMND 4.84%

CMPI 0.00%

CMPX -3.77%

CMRA 0.00%

CMRAW 33.33%

CMRX -1.63%

CNCE 0.00%

CNSP -38.81%

CNST 0.00%

CNTA -0.45%

CNTB -1.50%

CNTX -5.01%

COCP -2.78%

COEPW 32.45%

COGT -3.00%

CORT 1.48%

COYA 1.79%

CPRX -0.92%

CRBP -2.46%

CRBU -4.59%

CRDF -3.11%

CRGX -0.54%

CRIS -0.38%

CRNX -4.45%

CRSP -0.47%

CRTX 2.63%

CRVO -4.75%

CRVS 1.12%

CSBR -1.59%

CTCX -11.35%

CTIC 0.06%

CTMX -1.65%

CTNM 0.00%

CTXR 1.60%

CUE 8.64%

CVAC -1.27%

CVKD 0.15%

CWBR 2.80%

CYAD -12.96%

CYCC 8.03%

CYCCP 5.49%

CYCN 2.61%

CYT -2.27%

CYTK -2.16%

CYTO -2.73%

DARE 3.31%

DAWN -1.64%

DBTX -0.81%

DBVT 0.91%

DFFN 10.28%

DICE 0.06%

DMAC 13.27%

DNLI -1.79%

DNTH -6.19%

DOMH -1.58%

DRMA -2.15%

DRMAW -1.25%

DRNA 0.00%

DRTS 4.63%

DRTSW 0.00%

DRUG -7.39%

DSGN -0.60%

DTIL 0.89%

DYAI 5.37%

EARS -1.77%

EDIT -2.91%

EDSA -1.00%

EFTR 5.61%

EFTRW -74.07%

EIGR -9.21%

ELAB -2.01%

ELDN 6.72%

ELEV -4.15%

ELOX 7.69%

ELTX -0.88%

ELVN -4.94%

ELYM -3.91%

ENGN -0.33%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 5.75%

ENTA -1.47%

ENTO -3.31%

ENTX -1.10%

ENVB 1.42%

EPIX -0.72%

EPRX -2.97%

EPZM 0.00%

EQ 0.44%

EQRX -2.09%

EQRXW 0.00%

ERAS -0.24%

ERNA -0.96%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -2.23%

ETON 1.22%

ETTX 0.00%

EVAX -2.67%

EVGN 3.26%

EVLO 0.00%

EWTX -0.37%

EXAI -0.38%

EXEL -0.43%

EYEG -0.69%

EYEN 4.53%

EYPT 0.06%

FATE -6.99%

FBIO 0.59%

FBIOP 0.32%

FBLG -8.76%

FBRX -6.12%

FDMT -4.68%

FENC -1.16%

FGEN -4.70%

FHTX 0.00%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.53%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -1.07%

FULC -4.43%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.01%

GANX -2.31%

GBIO -2.83%

GBT 0.01%

GDTC 0.50%

GERN -4.42%

GHRS -2.59%

GLMD 0.50%

GLPG -2.34%

GLSI 1.40%

GLTO -0.18%

GLUE -3.41%

GLYC -14.25%

GMAB -0.08%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 1.33%

GNPX 6.13%

GNTA 3.94%

GOSS -3.87%

GOVX -9.15%

GOVXW -49.04%

GPCR -4.98%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 3.45%

GRTX 2.12%

GTHX 0.23%

GUTS -4.39%

GXGXW 41.67%

GYRE -2.32%

HALO -1.34%

HARP 0.09%

HCWB -7.81%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX 0.73%

HOOK 2.77%

HOTH -1.68%

HOWL -1.71%

HRMY 0.00%

HRTX 0.66%

HSTO 0.00%

HUMA 1.22%

HUMAW -0.01%

IBRX -5.00%

ICCC 0.22%

ICPT 0.21%

ICU 18.93%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.62%

IFRX -1.55%

IGMS -0.66%

IKNA -0.30%

IKT 1.42%

IMAB -1.74%

IMCR -3.65%

IMGN 0.02%

IMGO 0.00%

IMMP 4.56%

IMMX -3.53%

IMNM -3.29%

IMNN 2.34%

IMPL -27.27%

IMRA 15.96%

IMRN 0.00%

IMRX -1.05%

IMTX -1.71%

IMTXW 6.00%

IMUX 2.04%

IMV 0.00%

IMVT -2.74%

INAB 0.77%

INBX -0.66%

INCY -1.24%

INDP 10.20%

INFI -52.38%

INKT 0.01%

INM -5.90%

INMB 0.00%

INO -4.03%

INSM -0.98%

INTS -1.47%

INVA 0.19%

INZY 0.69%

IOBT -9.45%

IONS -0.84%

IOVA -2.19%

IPA 3.10%

IPHA 5.58%

IPSC -0.88%

IRON -3.39%

ISEE 0.38%

ITOS -1.37%

ITRM 2.50%

IVA 6.96%

IVVD -0.83%

JAGX 0.52%

JANX -3.88%

JAZZ -1.24%

JNCE 0.00%

JSPR -6.50%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -8.91%

KALV -1.77%

KDNY 0.22%

KMPH -0.34%

KNSA -2.42%

KNTE -0.38%

KOD -5.51%

KPRX -0.48%

KPTI -0.46%

KRBP -10.00%

KRON 1.06%

KROS -1.42%

KRRO -3.81%

KRTX 0.03%

KRYS -1.41%

KTRA 9.72%

KTTA 8.16%

KTTAW 0.92%

KURA -2.05%

KYMR -2.99%

KYTX -4.68%

KZIA 15.07%

KZR -0.21%

LABP 0.57%

LBPH -1.87%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.36%

LENZ -6.16%

LEXX -0.78%

LEXXW -14.63%

LGND -1.06%

LGNDV 0.00%

LGVN -9.03%

LIAN -8.28%

LIFE 2.70%

LIPO -11.35%

LIXT -3.77%

LIXTW 95.35%

LJPC -0.32%

LMNL 0.12%

LOGC 0.00%

LPCN -5.52%

LPTX -0.01%

LQDA -0.24%

LRMR -1.21%

LSTA -4.06%

LTRN 1.00%

LUMO -1.32%

LVTX 0.41%

LXEO -3.35%

LXRX -2.65%

LYEL -29.48%

LYRA -1.78%

MACK 0.10%

MBIO -10.96%

MBRX -0.71%

MCRB 6.61%

MDGL -3.11%

MDNA -13.16%

MDWD 0.48%

MDXG -2.43%

MEIP 0.24%

MESO -1.48%

MGNX -4.20%

MGTA -7.74%

MGTX -3.21%

MGX -2.68%

MIRM -1.77%

MIRO 0.59%

MIST 2.33%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -1.32%

MLYS -1.48%

MNKD -0.76%

MNMD -0.57%

MNOV 1.41%

MNPR -3.67%

MOLN 0.11%

MOR 1.06%

MORF -3.65%

MREO -2.71%

MRKR 2.57%

MRNA -4.99%

MRNS -4.04%

MRSN -2.38%

MRTX -0.17%

MRUS -0.12%

MRVI -0.73%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.24%

MYMD 2.70%

NAMS 0.65%

NAMSW 0.43%

NAUT 1.99%

NBRV 0.71%

NBSE -1.56%

NBTX 8.03%

NCNA 1.32%

NERV -3.48%

NEXI 2.60%

NGM -1.28%

NGNE -2.15%

NKGN 4.24%

NKGNW 8.00%

NKTR -4.21%

NKTX -3.75%

NLSP -1.35%

NLSPW 26.67%

NMRA -0.29%

NMTR -42.97%

NOVN -24.84%

NRBO 12.91%

NRIX -0.19%

NRSN -9.63%

NRSNW 0.00%

NRXP -8.94%

NRXPW 14.03%

NRXS -4.23%

NTBL 5.04%

NTEC -12.45%

NTHI 0.00%

NTLA -7.27%

NTRBW -31.07%

NUVL -1.84%

NVAX -2.68%

NVCT 0.07%

NVIV -34.28%

NXTC -3.82%

NYMX -0.05%

OABI 0.53%

OABIW -10.06%

OBIO -1.46%

OBSV 0.00%

OCEA -0.70%

OCGN 3.38%

OCS -1.02%

OCUL -4.12%

OCUP 1.63%

ODT -4.27%

OKYO 1.51%

OLMA -4.31%

OMER -2.70%

OMGA 3.75%

ONCO 10.99%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY -0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 0.77%

ORGS -0.09%

ORIC -4.15%

ORMP 14.73%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.13%

OVID -1.60%

OYST 0.00%

PALI -0.87%

PASG 2.05%

PBLA -7.50%

PBM -2.44%

PBYI 0.34%

PCSA 0.97%

PCVX -0.40%

PDSB 0.00%

PEPG 1.16%

PGEN -2.09%

PHAR 1.51%

PHAS 0.00%

PHAT -1.94%

PHIO -4.96%

PHIOW 36.47%

PHVS -6.38%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.83%

PLUR 4.35%

PMN 0.00%

PMVP 0.00%

PNT 0.16%

PPBT -1.06%

PRAX 1.47%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK 0.90%

PRQR 1.19%

PRTA -3.74%

PRTC -0.08%

PRTG 1.95%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -7.93%

PSTX -0.97%

PTCT -0.97%

PTE -0.82%

PTGX -2.48%

PTIXW -34.07%

PULM 2.63%

PXMD 0.00%

PYPD 0.07%

PYXS -0.98%

QLGN -6.67%

QNCX 3.56%

QNRX 0.33%

QSI -9.83%

QSIAW -3.13%

QTTB -5.82%

QURE -1.12%

RAIN -1.63%

RANI 2.40%

RAPT -4.87%

RARE 1.19%

RCKT -7.34%

REGN -1.35%

RENB -3.75%

REPL -2.05%

RETA 0.02%

REUN -0.89%

REVB -7.62%

REVBU 3.46%

REVBW 4.38%

RGLS -3.28%

RGNX -5.07%

RIGL -1.12%

RLAY -4.45%

RLMD 0.33%

RLYB -0.34%

RNA -1.42%

RNAC -2.47%

RNAZ 1.92%

RNXT 4.79%

ROIV -1.72%

ROIVW 4.56%

RPHM 0.62%

RPRX 0.26%

RPTX -2.90%

RUBY 2.70%

RVLP -32.05%

RVMD -1.52%

RVMDW 5.10%

RVNC 0.78%

RVPH 0.25%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.84%

RYTM -4.87%

RYZB 0.02%

RZLT 1.03%

SABS 0.00%

SABSW -11.81%

SAGE -0.37%

SANA -4.80%

SAVA -1.58%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 3.88%

SCPH -0.30%

SCPS 0.00%

SEEL -4.32%

SEER -0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.03%

SGMT 1.45%

SGTX -2.56%

SIOX 22.63%

SLDB -4.66%

SLGL 2.97%

SLN -3.26%

SLNO -2.85%

SLRX 7.29%

SLS -2.14%

SMMT 0.13%

SNDX -1.13%

SNGX 0.38%

SNPX -2.31%

SONN -1.06%

SPPI -0.49%

SPRB 0.91%

SPRC -4.69%

SPRO 0.23%

SRNE -25.00%

SRPT -1.84%

SRRA 0.00%

SRRK -3.97%

SRZN -2.45%

STAB 0.00%

STOK -4.23%

STRO -5.02%

STSA 0.00%

STTK -5.77%

SURF -0.93%

SVRA 1.45%

SWTX -0.51%

SYBX 0.00%

SYRS -1.72%

TALS -0.73%

TARA -6.65%

TARS -0.64%

TBPH 0.24%

TCBP 2.66%

TCDA 0.00%

TCON -3.36%

TCRR 0.00%

TCRT 1.57%

TCRX -0.72%

TECH -0.23%

TENX -1.27%

TERN -4.83%

TFFP -3.52%

TGTX -2.63%

THRX 0.12%

TIL 0.02%

TLC 0.00%

TLSA -0.53%

TNGX -2.48%

TNXP -4.40%

TNYA -4.41%

TPST 0.73%

TRDA -2.71%

TRVI -1.53%

TRVN 4.98%

TSHA -21.54%

TSVT -3.72%

TTNP -4.07%

TVTX -0.88%

TYRA -6.12%

UBX -0.48%

UNCY -3.80%

URGN -2.68%

UTHR -0.32%

VACC 11.36%

VALN -2.50%

VAXX 248.00%

VBIV 0.76%

VBLT -8.77%

VCEL -1.58%

VCNX 9.01%

VCYT -0.97%

VERA -3.29%

VERU 1.62%

VERV -2.49%

VIGL 4.30%

VINC 1.78%

VIR 0.00%

VIRI -0.85%

VIRX 3.24%

VKTX -1.07%

VLON -13.04%

VNDA -1.71%

VOR -4.03%

VRCA -0.06%

VRDN -4.27%

VRNA -0.66%

VRPX 0.40%

VRTX 0.03%

VSTM -3.73%

VTGN -2.26%

VTVT -6.43%

VTYX -2.30%

VXRT -0.19%

VYGR -2.42%

VYNE -3.15%

VYNT 7.78%

WINT -3.24%

WVE -3.77%

XBIO 0.97%

XBIT -3.54%

XCUR 6.28%

XENE -2.59%

XERS 0.71%

XFOR 3.96%

XLO 4.43%

XLRN 0.00%

XNCR -0.41%

XOMA -1.45%

XOMAO 0.36%

XOMAP -0.82%

XRTX -7.04%

YMAB -2.20%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.29%

ZNTL -2.86%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-09-01	Buck Kristen K	Buy	58 000	Common Stock
2022-09-01	Buck Kristen K	Sell	44 776	Common Stock
2022-09-01	Mazzo David J	Buy	150 000	Common Stock
2022-09-01	Mazzo David J	Sell	69 742	Common Stock
2022-01-13	Mazzo David J	Sell	6 471	Common Stock

INSIDER POWER
28.99
Last 95 transactions
Buy: 2 781 590 \| Sell: 342 279

ボリューム相関

長: -0.14 (neutral)

短: -0.99 (very strong negative)

Signal:(28.424) Possible Trading Opportunity Present (swing)

Caladrius Biosciences, 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Caladrius Biosciences, 相関 - 通貨/商品

0.30
( neutral )

0.32
( neutral )

0.00
( neutral )

-0.03
( neutral )

Caladrius Biosciences, 財務諸表

Annual	2021
収益:	$0.00
総利益:	$0.00 (0.00 %)
EPS:	$-1.779

FY	2021
収益:	$0.00
総利益:	$0.00 (0.00 %)
EPS:	$-1.779

FY	2020
収益:	$0.00
総利益:	$0.00 (0.00 %)
EPS:	$-0.530

FY	2019
収益:	$0.00
総利益:	$0.00 (0.00 %)
EPS:	$-1.880

Financial Reports:

No articles found.

Caladrius Biosciences, Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Caladrius Biosciences, Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$0.250	2011-04-04
Last Dividend	$0.310	2013-10-28
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	$0.560	--
Avg. Dividend % Per Year	0.00%	--
Score	0.22	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2026-04-06)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

0.22

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
28 Oct 2013	$0.310	30 Nov -0001	30 Nov -0001	30 Nov -0001
04 Apr 2011	$0.250	30 Nov -0001	30 Nov -0001	30 Nov -0001

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Diamond	2024-09-16	Monthly	14	15.03%	9.60
DMLP	Dividend Diamond	2024-04-26	Quarterly	22	10.71%	9.35
OXSQ	Dividend Diamond	2024-09-16	Monthly	21	12.73%	9.02
ARLP	Dividend Royal	2024-05-07	Quarterly	26	9.67%	8.87
PNNT	Dividend Royal	2024-06-14	Monthly	18	9.49%	8.82
MFIC	Dividend Royal	2024-06-11	Quarterly	21	10.89%	8.79
SPOK	Dividend Royal	2024-05-23	Quarterly	20	8.73%	8.72
PSEC	Dividend Royal	2024-06-25	Monthly	21	9.03%	8.65
SBLK	Dividend Royal	2024-06-06	Quarterly	17	13.10%	8.63
GBDC	Dividend Royal	2024-11-29	Bi-Monthly	15	8.53%	8.62

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	-0.283	1.200	-9.44	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.441	1.500	-6.01	-9.02	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	21.00	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	21.03	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	21.00	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-1.441	2.00	-0.480	-0.960	[0 - 30]
freeCashFlowPerShareTTM	-1.445	2.00	-0.722	-1.445	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0	1.000	-3.33	-3.33	[0.2 - 0.8]
operatingProfitMarginTTM	0	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.965

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.240	1.000	-0.125	0	[1 - 100]
returnOnEquityTTM	-0.441	2.50	-3.87	-9.02	[0.1 - 1.5]
freeCashFlowPerShareTTM	-1.445	2.00	-0.482	-1.445	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-1.441	2.00	-0.480	-0.960	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0197	1.500	-3.46	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-1.941

Caladrius Biosciences, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Caladrius Biosciences,

Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.